We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Software Platform Extends MS Analysis to Include Small Molecules

By HospiMedica staff writers
Posted on 05 Jun 2008
Print article
A new software platform has extended its mass spectrometry (MS) franchise to include small molecules in addition to protein analysis.

Although MS manufacturers are selling an increasing number of instruments for small molecule analysis, the bioinformatics aspect has been mostly underdeveloped. The new software program, SmileMS, offers robust, machine-independent software for the analysis of MS spectra from small molecules; a modern and dynamic user interface enabling users to seamlessly navigate through and share their results; and an open database of small molecule spectra allowing users to add both public and private data, enrich their proper search domain, and more share the database with other users.

SmileMS is a unique software platform for the identification and analysis of small molecules by liquid chromatography-mass spectrometry techniques. Developed by Geneva Bioinformatics (GeneBio; Geneva, Switzerland), in collaboration with the Swiss Institute of Bioinformatics (SIB; Geneva, Switzerland) and Prof. Denis Hochstrasser's group at Geneva University Hospitals (Geneva, Switzerland), SmileMS targets a growing need a growing need for efficient and automatable processes for routine daily analysis of small molecules.

Prof. Denis Hochstrasser said, "My lab has been thoroughly working with the GeneBio team for more than a year now and we are very happy with the quality of the results SmileMS is producing in its early version. The tool by far surpasses other tools we have tested for both the quality of its results, its user-friendliness, and most importantly its extreme flexibility; using the same tool and databases with different separation methods and instruments as well as sharing the results amongst different users through Web access show great promise for routine clinical application.”


Related Links:
Geneva University Hospitals
Geneva Bioinformatics
Swiss Institute of Bioinformatics
Gold Member
12-Channel ECG
CM1200B
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Electrocardiograph
SE-1200 Pro/SE-1201 Pro
New
Blood Sampling System
SafeSet

Print article

Channels

Critical Care

view channel
Image: The microfluidic chip analyzes the chemotactic migration behaviors of neutrophils in sepsis patients (Talanta, 2024; DOI: 10.1016/j.talanta.2024.126801)

Microfluidic Chip Method to Improve Sepsis Diagnosis, Progression Evaluation and Prognosis Monitoring

Sepsis, a severe and life-threatening condition, results from an uncontrolled immune response that can lead to multi-organ failure. Given its high mortality rate and the limitations of current diagnostic... Read more

Surgical Techniques

view channel
Image: Illustration of how the razor-sharp flakes of graphene line up together on a surface and can kill bacteria without harming healthy human cells (Photo courtesy of Yen Sandqvist)

Ultra-Thin Graphene-Based Coating Material Paves Way for Bacteria-Killing Medical Devices

Healthcare-associated infections are a significant global issue, leading to immense suffering, increased healthcare costs, and a greater risk of antibiotic resistance. These infections often occur when... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.